Dimensional Fund Advisors’s Opiant Pharmaceuticals, Inc. Common Stock OPNT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-100,209
| Closed | -$2.03K | – | 3536 |
|
2022
Q4 | $2.03K | Sell |
100,209
-12,283
| -11% | -$249 | ﹤0.01% | 2723 |
|
2022
Q3 | $1.21M | Sell |
112,492
-14,800
| -12% | -$159K | ﹤0.01% | 2840 |
|
2022
Q2 | $1.53M | Buy |
127,292
+20,610
| +19% | +$247K | ﹤0.01% | 2821 |
|
2022
Q1 | $2.29M | Buy |
106,682
+40,031
| +60% | +$857K | ﹤0.01% | 2790 |
|
2021
Q4 | $2.24M | Buy |
66,651
+22,543
| +51% | +$758K | ﹤0.01% | 2818 |
|
2021
Q3 | $1.14M | Buy |
44,108
+22,346
| +103% | +$575K | ﹤0.01% | 3020 |
|
2021
Q2 | $301K | Sell |
21,762
-69
| -0.3% | -$954 | ﹤0.01% | 3256 |
|
2021
Q1 | $232K | Buy |
21,831
+2,253
| +12% | +$23.9K | ﹤0.01% | 3266 |
|
2020
Q4 | $158K | Hold |
19,578
| – | – | ﹤0.01% | 3250 |
|
2020
Q3 | $146K | Buy |
19,578
+5,644
| +41% | +$42.1K | ﹤0.01% | 3235 |
|
2020
Q2 | $125K | Hold |
13,934
| – | – | ﹤0.01% | 3257 |
|
2020
Q1 | $133K | Buy |
+13,934
| New | +$133K | ﹤0.01% | 3247 |
|